Profound Medical Corp. (PRN.TO)
CAD 7.34
(9.55%)
CAD 7.34
(9.55%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -26.78 Million USD | -1.96% |
| 2022 | -34.63 Million USD | 10.34% |
| 2021 | -28.64 Million USD | -70.82% |
| 2020 | -19.49 Million USD | -25.79% |
| 2019 | -12.52 Million CAD | 0.15% |
| 2018 | -13.24 Million CAD | -0.12% |
| 2017 | -16.77 Million CAD | -16.21% |
| 2016 | -15.56 Million CAD | -21.27% |
| 2015 | -11.14 Million CAD | -51.85% |
| 2014 | -6.31 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -7.54 Million USD | 1.45% |
| 2024 Q1 | -7.17 Million USD | 1.75% |
| 2023 FY | - USD | -1.96% |
| 2023 Q3 | -6.27 Million USD | -1.85% |
| 2023 Q2 | -6.15 Million USD | 0.96% |
| 2023 Q4 | -7.79 Million USD | -24.25% |
| 2023 Q1 | -6.21 Million USD | -12.7% |
| 2022 Q1 | -6.73 Million USD | 29.78% |
| 2022 Q2 | -7.03 Million USD | -4.5% |
| 2022 FY | - USD | 10.34% |
| 2022 Q3 | -7.61 Million USD | -8.18% |
| 2022 Q4 | -5.51 Million USD | 27.53% |
| 2021 Q1 | -6.09 Million USD | -46.43% |
| 2021 FY | - USD | -70.82% |
| 2021 Q4 | -9.59 Million USD | -35.12% |
| 2021 Q3 | -7.09 Million USD | -20.98% |
| 2021 Q2 | -5.86 Million USD | 3.8% |
| 2020 Q4 | -4.16 Million USD | 7.12% |
| 2020 FY | - USD | -25.79% |
| 2020 Q1 | -4.23 Million CAD | -12.08% |
| 2020 Q2 | -3.4 Million CAD | 19.56% |
| 2020 Q3 | -4.48 Million CAD | -31.77% |
| 2019 Q4 | -3.77 Million CAD | 8.78% |
| 2019 FY | - CAD | 0.15% |
| 2019 Q2 | -3.78 Million CAD | -144.65% |
| 2019 Q1 | -1.54 Million CAD | 38.95% |
| 2019 Q3 | -4.13 Million CAD | -9.38% |
| 2018 Q3 | -3.55 Million CAD | 7.92% |
| 2018 Q4 | -2.53 Million CAD | 28.76% |
| 2018 FY | - CAD | -0.12% |
| 2018 Q1 | -3.22 Million CAD | -8.42% |
| 2018 Q2 | -3.86 Million CAD | -19.88% |
| 2017 FY | - CAD | -16.21% |
| 2017 Q2 | -3.41 Million CAD | -21.38% |
| 2017 Q3 | -3.63 Million CAD | -6.27% |
| 2017 Q4 | -2.97 Million CAD | 18.27% |
| 2017 Q1 | -2.81 Million CAD | 15.74% |
| 2016 Q1 | -2.71 Million CAD | -79.11% |
| 2016 Q4 | -3.34 Million CAD | -18.85% |
| 2016 Q3 | -2.81 Million CAD | -8.91% |
| 2016 Q2 | -2.58 Million CAD | 4.9% |
| 2016 FY | - CAD | -21.27% |
| 2015 Q1 | 19.84 Thousand CAD | -85.19% |
| 2015 Q2 | -3.88 Million CAD | -19696.5% |
| 2015 Q3 | -1.98 Million CAD | 49.06% |
| 2015 Q4 | -1.51 Million CAD | 23.43% |
| 2015 FY | - CAD | -51.85% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q3 | -246.41 Thousand CAD | 0.0% |
| 2014 Q4 | 134 Thousand CAD | 154.38% |
| 2014 Q1 | -21.17 Thousand CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|